Cargando…

Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients

A common splice variant in HSD17B13 (rs72613567:TA) was recently found to be associated with a reduced risk of developing chronic liver disease in NAFLD patients and a reduced risk of progression to advanced fibrosis and cirrhosis. In this study, we aimed to evaluate the prognosis of cirrhotic patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gil-Gómez, Antonio, Rojas, Ángela, García-Lozano, María R., Muñoz-Hernández, Rocío, Gallego-Durán, Rocío, Maya-Miles, Douglas, Montero-Vallejo, Rocío, Gato, Sheila, Gallego, Javier, Francés, Rubén, Soriano, Germán, Ampuero, Javier, Romero-Gómez, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569581/ https://www.ncbi.nlm.nih.gov/pubmed/36233142 http://dx.doi.org/10.3390/ijms231911840

Ejemplares similares

Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
por: Ampuero, Javier, et al.
Publicado: (2022)

Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
por: Gallego-Durán, Rocío, et al.
Publicado: (2021)

Hepatitis C Virus Clearance by Direct-Acting Antivirals Agents Improves Endothelial Dysfunction and Subclinical Atherosclerosis: HEPCAR Study
por: Muñoz-Hernández, Rocío, et al.
Publicado: (2020)

Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- and long-term prediction of hepatocellular carcinoma among cirrhotic patients
por: Gil-Gómez, Antonio, et al.
Publicado: (2021)

Extracellular Vesicles as Biomarkers in Liver Disease
por: Muñoz-Hernández, Rocío, et al.
Publicado: (2022)

Emerging pharmacological treatment options for MAFLD
por: Rojas, Ángela, et al.
Publicado: (2022)

Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
por: Gallego-Durán, Rocío, et al.
Publicado: (2022)

Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver
por: López-Bermudo, Lucía, et al.
Publicado: (2022)

Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
por: Marañón, Patricia, et al.
Publicado: (2022)

Impact of COVID-19 on liver disease: From the experimental to the clinic perspective
por: Gato, Sheila, et al.
Publicado: (2021)

Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis
por: Marañón, Patricia, et al.
Publicado: (2023)

Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy
por: del Campo, José A., et al.
Publicado: (2018)

Mechanistic PK-PD model of alendronate treatment of postmenopausal osteoporosis predicts bone site-specific response
por: Calvo-Gallego, José L., et al.
Publicado: (2022)

Antiviral Therapy in HCV-infected Decompensated Cirrhotics
por: Danish, Fazal A., et al.
Publicado: (2010)

Wilson's disease: Revisiting an old friend
por: Lucena-Valera, Ana, et al.
Publicado: (2021)

Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension
por: Scheiner, Bernhard, et al.
Publicado: (2019)

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Del Campo, José A, et al.
Publicado: (2018)

Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients
por: Ventura-Cots, Meritxell, et al.
Publicado: (2017)

Blood Microbiome Quantity and the Hyperdynamic Circulation in Decompensated Cirrhotic Patients
por: Traykova, Daniela, et al.
Publicado: (2017)

Nutritional Deficiencies and Clinical Practices in Decompensated Cirrhotics With Hepatic Encephalopathy
por: Panchani, Nishah N, et al.
Publicado: (2022)

Cardiac complications in a geriatric population hospitalized with COVID-19: The OCTA-COVID cohort
por: Mónica, Ramos-Sánchez, et al.
Publicado: (2022)

Synthesis of 1,4-Biphenyl-triazole Derivatives as Possible 17β-HSD1 Inhibitors: An in Silico Study
por: Hernández-López, Hiram, et al.
Publicado: (2020)

Hydrogels for neuroprotection and functional rewiring: a new era for brain engineering
por: Fernández-Serra, Rocío, et al.
Publicado: (2019)

Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies
por: Rojas, Ángela, et al.
Publicado: (2022)

Fondaparinux is effective for acute portal vein thrombosis in decompensated cirrhotic patients
por: Zhang, Zhi-Hao, et al.
Publicado: (2017)

Management of Hepatocellular Carcinoma in Decompensated Cirrhotic Patients: A Comprehensive Overview
por: Tampaki, Maria, et al.
Publicado: (2023)

Liver Disease Undernutrition Screening Tool Questionnaire Predicts Decompensation and Mortality in Cirrhotic Outpatients with Portal Hypertension
por: Casas-Deza, Diego, et al.
Publicado: (2023)

Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy
por: Seraj, Siamak M, et al.
Publicado: (2017)

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
por: Yen, Fu‐Shun, et al.
Publicado: (2021)

Protective Effect of Resveratrol against Hexavalent Chromium-Induced Genotoxic Damage in Hsd:ICR Male Mice
por: Nicolás-Méndez, Tonancy, et al.
Publicado: (2022)

Visualizing Research on Industrial Clusters and Global Value Chains: A Bibliometric Analysis
por: González-Torres, Thais, et al.
Publicado: (2020)

Investing Time and Resources for Work–Life Balance: The Effect on Talent Retention
por: Rodríguez-Sánchez, José-Luis, et al.
Publicado: (2020)

Digitalization and digital transformation in higher education: A bibliometric analysis
por: Díaz-García, Vicente, et al.
Publicado: (2022)

Corrigendum: Digitalization and digital transformation in higher education: A bibliometric analysis
por: Díaz-García, Vicente, et al.
Publicado: (2023)

A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
por: Guo, Feifei, et al.
Publicado: (2021)

Modulation of Inflammatory Response in a Cirrhotic Rat Model with Induced Bacterial Peritonitis
por: Sánchez, Elisabet, et al.
Publicado: (2013)

Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
por: Gallego-Durán, Rocío, et al.
Publicado: (2016)

Comparative Efficacy of Active Group Music Intervention versus Group Music Listening in Alzheimer’s Disease
por: Gómez-Gallego, María, et al.
Publicado: (2021)

The Impact of Previous Acute Decompensation on the Long-Term Prognosis of Alcoholic Hepatitis in Cirrhotic Patients
por: Yoon, Eileen L., et al.
Publicado: (2019)

Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9rr2nfd9sphc56lo2esbvtpkvc